Quantum Biopharma (QNTM) Interest Expenses (2019 - 2026)
Quantum Biopharma recorded quarterly Interest Expenses of $22854.0 in Q1 2026, down 85.54% quarter-over-quarter from $158063.0 in Q4 2025, and up 3.09% year-over-year from $22168.0 in Q1 2025.
Quantum Biopharma's Interest Expenses history runs 8 years deep, the most recent figure standing at $22854.0 for Q1 2026.
- In Q1 2026, Interest Expenses rose 3.09% year-over-year to $22854.0; the TTM figure through Mar 2026 stood at $389449.0 (up 810.54% YoY), while the FY2025 annual figure was $158063.0, up 378.73% from the prior year.
- Interest Expenses came in at $22854.0 for Q1 2026 at Quantum Biopharma, down from $158063.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $158063.0 in Q4 2025 to a low of -$20902.0 in Q4 2023.
- A 5-year average of $30859.7 and a median of $17852.5 in 2022 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses slumped 122.81% in 2023 and surged 8330.03% in 2025, its largest moves.
- Quantum Biopharma's Interest Expenses stood at -$9381.0 in 2022, then plunged by 122.81% to -$20902.0 in 2023, then surged by 108.97% to $1875.0 in 2024, then soared by 8330.03% to $158063.0 in 2025, then tumbled by 85.54% to $22854.0 in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $22854.0, $158063.0, and $91570.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 12.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,854.00 |
| Mar 31, 2026 | 22,854.00 |
| Dec 31, 2025 | -72,637.00 |
| Dec 31, 2025 | -72,637.00 |
| Sep 30, 2025 | 91,570.00 |
| Sep 30, 2025 | 91,570.00 |
| Jun 30, 2025 | 116,962.00 |
| Jun 30, 2025 | 116,962.00 |
| Mar 31, 2025 | 25,374.00 |
| Mar 31, 2025 | 25,374.00 |
| Dec 31, 2024 | 1,875.00 |
| Dec 31, 2024 | 1,875.00 |
| Sep 30, 2024 | 10,371.00 |
| Sep 30, 2024 | 10,371.00 |
| Jun 30, 2024 | 8,357.00 |
| Jun 30, 2024 | 8,357.00 |
| Mar 31, 2024 | 12,414.00 |
| Mar 31, 2024 | 12,414.00 |
| Dec 31, 2023 | -20,902.00 |
| Dec 31, 2023 | -20,902.00 |
| Sep 30, 2023 | 20,534.00 |
| Sep 30, 2023 | 20,534.00 |
| Mar 31, 2023 | 2,373.00 |
| Mar 31, 2023 | 2,373.00 |
| Dec 31, 2022 | -9,381.00 |
| Dec 31, 2022 | -9,381.00 |
| Sep 30, 2022 | 19,323.00 |
| Sep 30, 2022 | 19,323.00 |
| Jun 30, 2022 | 19,265.00 |
| Jun 30, 2022 | 19,265.00 |
| Mar 31, 2022 | 19,615.00 |
| Mar 31, 2022 | 19,615.00 |
| Jun 30, 2021 | 18,917.00 |
| Jun 30, 2021 | 18,917.00 |
| Mar 31, 2021 | 19,325.00 |
| Mar 31, 2021 | 19,325.00 |
| Sep 30, 2020 | 60,824.84 |
| Sep 30, 2020 | 60,824.84 |
| Jun 30, 2020 | 49,383.72 |
| Jun 30, 2020 | 49,383.72 |
| Mar 31, 2020 | 54,571.89 |
| Mar 31, 2020 | 54,571.89 |
| Dec 31, 2019 | 83,773.26 |
| Dec 31, 2019 | 83,773.26 |